May 27, 2020
InMed Releases CBN Preclinical Results in Glaucoma
May 14, 2020
InMed Pharmaceuticals Reports Third Quarter Fiscal 2020 Financial Results and Provides R&D and Business Update
Apr 08, 2020
MMJ International Holdings Ships First-Ever Marijuana Extracts to USA
Apr 01, 2020
InMed Announces Completion of Initial Phase 1 Clinical Trial of INM-755 CBN Cream in Healthy Subjects
Mar 26, 2020
What Makes Menthol Such A Powerful Medicinal Ingredient?
Mar 23, 2020
A first-of-its-kind permit to export cannabis oil from the US to Israel was granted to Panaxia and its partner Ultra Health
Mar 17, 2020
Hemp-based products of Panaxia US and partner Ultra Health receive distribution and manufacturing license: Having passed the New Mexico NMED audit, Panaxia US received a first-of-its-kind license to manufacture and distribute products throughout the US
Mar 12, 2020
American Shaman Debuts First-Of-Its-Kind Sleep Product
Mar 10, 2020
InMed Pharmaceuticals Announces Completed Enrollment in Phase 1 Clinical Trial of INM-755 CBN Cream in Healthy Subjects
Mar 09, 2020
Senzer Secures US Clinical Data Package for the Treatment of Chemotherapy Induced Adverse Events
Mar 05, 2020
FDA Advances Work Related to Cannabidiol Products with Focus on Protecting Public Health, Providing Market Clarity
Feb 27, 2020
Nextleaf Solutions Prepares for Potential Pharmaceutical Participation with Prodrug Patent
Feb 20, 2020
Health Canada-DEA Approves MMJ International Holdings To Ship THC
Feb 18, 2020
Cannabics Pharmaceuticals Study Shows Cannabinoids CBNA and CBCA Cause Necrosis Similarly to their Non-acidic Form
Jan 30, 2020
ScriptDrop's Integrated Delivery Solution Helps Increase Medication Adherence and Reduce Return to Stock for Total Health Care by 88% in Pilot Store
Jan 29, 2020
Elixicure CBD-Infused Pain Relief Product Receives FDA Certification
Jan 21, 2020
InMed Expands on Announcement of Cannabinol (CBN) Therapeutic Leadership with New Website Content and CEO Interview
Jan 20, 2020
InMed First to Advance Cannabinol (CBN) into Therapeutic Clinical Trials
Jan 09, 2020
Cannabics Pharmaceuticals Announces Cannabigerol (CBG) Shown to Have Anti-tumor Properties
Jan 07, 2020
MMJ International Holdings Overcomes Big Federal Deterrents In It's Marijuana Drug Development Strategy